6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
29m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
55m ago	CPKC increases dividend by 17.5 percent
55m ago	Waldencast announces conclusion of SEC investigation
56m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
56m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Marvel Biosciences Corp (V:MRVL) — investor relations, events, news, and company updates on 6ix.

Latest News

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Marvel Biosciences Announces Closing of Convertible Debenture Offering

Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Financials

Revenue

CA$0

Market Cap

CA$10.44 M

EPS

-0.05

Community Chat

Ask AI